Colgate Palmolive (India) stock gains after strong Q1 results and Piper Sandler target cut

Colgate Palmolive (India) stock (ISIN INE259A01022) traded at around INR 1,917.80 on the National Stock Exchange as of September 18, 2026, up 4.21 percent on the day and still below its recent 52-week high, giving investors a clearer picture of its current valuation.

Q1 2026 results support the India business

For a broader view of the Colgate franchise, investors often look at the consolidated figures of Colgate-Palmolive Company, which reported solid numbers for Q1 2026. According to Investing.com, Colgate-Palmolive delivered earnings per share of USD 0.97 in Q1 2026, beating the consensus forecast of USD 0.94 and underscoring the group’s ability to manage costs and pricing in a challenging environment.

In the same Q1 2026 period, Colgate-Palmolive’s revenue reached USD 5.32 billion compared with expectations of USD 5.22 billion, a positive surprise of around USD 0.10 billion that points to resilient demand across oral care and personal care categories worldwide, even as input costs remain volatile, per Investing.com.

Valuation and margin signals from Piper Sandler

The most prominent recent analyst move comes from Piper Sandler, which updated its view on the New York listed Colgate-Palmolive Company on September 21, 2026. As Investing.com reports, Piper Sandler lowered its price target on Colgate-Palmolive Company from USD 98 to USD 95 while maintaining an Overweight rating, citing ongoing cost pressures as a key risk factor for margins.

According to the same update from Investing.com, Piper Sandler kept its 2026 earnings per share estimate for Colgate-Palmolive at USD 3.85 but trimmed the 2027 EPS forecast to USD 4.12 from USD 4.23, indicating a roughly 2.6 percent reduction in the longer-term outlook and highlighting that higher input and logistics costs could still limit upside even after recent price increases.

Another valuation lens comes from GuruFocus. As GuruFocus notes, Colgate-Palmolive’s GF Value, a proprietary fair value estimate, stands at USD 95.37 versus a current stock price of about USD 87.47, implying the shares are undervalued by around 8.3 percent at that level.

Stock level and market perspective

Per data from Investing.com, the New York listed Colgate-Palmolive Company stock recently traded around USD 87.32, below its 52-week high of USD 99.33 and above its 52-week low, placing it at a moderate discount to its peak while still reflecting the market’s confidence in the company’s dividend record and defensive profile.

For Colgate Palmolive (India) stock, the latest available closing figure of INR 1,917.80 on the National Stock Exchange as of September 18, 2026, represented a 4.21 percent rise on that trading day compared with the prior close, according to price data from an Indian stock portal, and positioned the shares comfortably within their recent trading range rather than at an extreme high or low.

More news and analyses on Colgate Palmolive (India) stock